GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer’s disease mouse model
Brain, Behavior, and Immunity · 2024-01 · 115 · 295-307
DOI: 10.1016/j.bbi.2023.10.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2024-01. Verfasst von Hyunhee Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, 153, Gyeongchun-ro, Guri-si, Gyeonggi-do 11923, So…. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Medical Research Center Oulu, GemVax and KAEL.
Themen: Demenz
Abstract (Originalsprache)
GV1001 protects neural cells from amyloid-β (Aβ) toxicity and other stressors in in vitro studies and demonstrates clinically beneficial effects in patients with moderate to severe Alzheimer's disease (AD). Here, we investigated the protective effects and mechanism of action of GV1001 in triple transgenic AD (3xTg-AD) mice. We found that GV1001 improved memory and cognition in middle- and old-aged 3xTg-AD mice. Additionally, it reduced Aβ oligomer and phospho-tau (Ser202 and Thr205) levels in the brain, and mitigated neuroinflammation by promoting a neuroprotective microglial and astrocyte phenotype while diminishing the neurotoxic ones. In vitro, GV1001 bound to gonadotropin releasing hormone receptors (GnRHRs) with high affinity. Levels of cyclic adenosine monophosphate, a direct downstream effector of activated GnRHRs, increased after GV1001 treatment. Furthermore, inhibition of GnRHRs blocked GV1001-induced effects. Thus, GV1001 might improve cognitive and memory functions of 3xTg-AD mice by suppressing neuroinflammation and reducing Aβ oligomers levels and phospho-tau by activating GnRHRs and their downstream signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, 153, Gyeongchun-ro, Guri-si, Gyeonggi-do 11923, South Korea.
- Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, 153, Gyeongchun-ro, Guri-si, Gyeonggi-do 11923, South Korea.
- Department of Radiology, Hanyang University Guri Hospital, Hanyang University College of Medicine, 153, Gyeongchun-ro, Guri-si, Gyeonggi-do 11923, South Korea.
- Teloid Inc., 3580 Wilshire Boulevard, Suite 900-31, Los Angeles, CA 90010, USA. Electronic address: chiron@gemvax.com.
- Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, 153, Gyeongchun-ro, Guri-si, Gyeonggi-do 11923, South Korea; Department of Translational Medicine, Hanyang University Gr…
Förderung
- National Research Foundation of Korea
- Medical Research Center Oulu
- GemVax and KAEL
- Korea Dementia Research Center
- Hanyang University
- Ministry of Health and Welfare
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Park, H., Kwon, H. S., Lee, K. Y., Kim, Y. E., Son, J. W., Choi, N. Y., Lee, E. J., Han, M. H., Park, D. W., Kim, S., & Koh, S. H. (2024). GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer’s disease mouse model. Brain, Behavior, and Immunity, 115, 295-307. https://doi.org/10.1016/j.bbi.2023.10.021
Vancouver
Park H, Kwon HS, Lee KY, Kim YE, Son JW, Choi NY, et al. GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer’s disease mouse model. Brain, Behavior, and Immunity. 2024;115:295-307. doi:10.1016/j.bbi.2023.10.021
BibTeX
@article{Park2024,
author = {Park, Hyunhee and Kwon, Hyuk Sung and Lee, Kyu-Yong and Kim, Ye Eun and Son, Jeong-Woo and Choi, Na-Young and Lee, Eun Ji and Han, Myung-Hoon and Park, Dong Woo and Kim, Sangjae and Koh, Seong-Ho},
title = {GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer’s disease mouse model},
journal = {Brain, Behavior, and Immunity},
year = {2024},
volume = {115},
pages = {295--307},
doi = {10.1016/j.bbi.2023.10.021}
}
EUVIMED